Literature DB >> 21998049

Improved prediction of poor outcome after thrombolysis using conservative definitions of symptomatic hemorrhage.

Christoph Gumbinger1, Philipp Gruschka, Markus Böttinger, Kristin Heerlein, Robin Barrows, Werner Hacke, Peter Ringleb.   

Abstract

BACKGROUND AND
PURPOSE: Direct comparison of symptomatic intracerebral hemorrhage (sICH) rates among different thrombolysis studies is complicated by the variability of definitions of sICH. The prediction of outcome still remains unclear.
METHODS: Baseline data and clinical courses of patients treated with thrombolytic therapy were collected in a prospective database. The 3-month outcome was evaluated using the modified Rankin Scale. Results of 24-hour follow-up imaging were reevaluated by at least 2 independent raters. Four common definitions of sICH (National Institute of Neurological Disorders and Stroke [NINDS], European Cooperative Acute Stroke Study [ECASS] 2, Safe Implementation of Thrombolysis in Stroke [SITS], ECASS 3) were applied. Kappa interrater statistics were calculated. Our objective was to find the sICH definition with the highest predictive value for mortality, poor (modified Rankin Scale 5 or 6) and unfavorable (modified Rankin Scale ≥3) clinical outcome after 90 days.
RESULTS: The data of 314 patients were analyzed. The NINDS definition revealed the highest sICH rate (7.7%); the lowest rate was found for the ECASS 3 definition (3.2%) of sICH. The highest interrater agreement was found for the ECASS 2 definition (κ 0.85) and the lowest for the NINDS definition (κ 0.57). Patients with sICH according to the SITS definition had the highest risk for death (OR, 14.4) and poor outcome (OR, 26.6).
CONCLUSIONS: None of the different definitions contains an optimal combination of prediction of mortality and outcome and a high interrater agreement rate. For the clinical evaluation of mortality, we recommend using the SITS definition; for studies needing a high interrater agreement rate, we recommend using the ECASS 2 definition. Due to the lack of 1 single optimal definition, future thrombolytic trials should preferably use different definitions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21998049     DOI: 10.1161/STROKEAHA.111.623033

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  28 in total

1.  Predictors of in-hospital death and symptomatic intracranial hemorrhage in patients with acute ischemic stroke treated with thrombolytic therapy: Paul Coverdell Acute Stroke Registry 2008-2012.

Authors:  Xin Tong; Mary G George; Quanhe Yang; Cathleen Gillespie
Journal:  Int J Stroke       Date:  2013-09-12       Impact factor: 5.266

2.  Endovascular Thrombectomy in Acute Ischemic Stroke: Outcome in Referred Versus Directly Admitted Patients.

Authors:  Philipp Bücke; Marta Aguilar Pérez; Elisabeth Schmid; Christian H Nolte; Hansjörg Bäzner; Hans Henkes
Journal:  Clin Neuroradiol       Date:  2017-01-31       Impact factor: 3.649

Review 3.  Symptomatic intracerebral hemorrhage in acute ischemic stroke after thrombolysis with intravenous recombinant tissue plasminogen activator: a review of natural history and treatment.

Authors:  Shadi Yaghi; Andrew Eisenberger; Joshua Z Willey
Journal:  JAMA Neurol       Date:  2014-09       Impact factor: 18.302

4.  Predictors and clinical relevance of hemorrhagic transformation after endovascular therapy for anterior circulation large vessel occlusion strokes: a multicenter retrospective analysis of 1122 patients.

Authors:  Raul G Nogueira; Rishi Gupta; Tudor G Jovin; Elad I Levy; David S Liebeskind; Osama O Zaidat; Ansaar Rai; Joshua A Hirsch; Daniel P Hsu; Marilyn M Rymer; Ashis H Tayal; Ridwan Lin; Sabareesh K Natarajan; Ashish Nanda; Melissa Tian; Qing Hao; Junaid S Kalia; Michael Chen; Alex Abou-Chebl; Thanh N Nguyen; Albert J Yoo
Journal:  J Neurointerv Surg       Date:  2014-01-08       Impact factor: 5.836

Review 5.  [Appropriate treatment of acute stroke at all times and in all places : Organizational concepts and new approaches].

Authors:  J E Weber; H J Audebert
Journal:  Internist (Berl)       Date:  2017-11       Impact factor: 0.743

Review 6.  Therapies for Hemorrhagic Transformation in Acute Ischemic Stroke.

Authors:  Joshua A Stone; Joshua Z Willey; Salah Keyrouz; James Butera; Ryan A McTaggart; Shawna Cutting; Brian Silver; Bradford Thompson; Karen L Furie; Shadi Yaghi
Journal:  Curr Treat Options Neurol       Date:  2017-01       Impact factor: 3.598

7.  TURN: A Simple Predictor of Symptomatic Intracerebral Hemorrhage After IV Thrombolysis.

Authors:  David Asuzu; Karin Nyström; Hardik Amin; Joseph Schindler; Charles Wira; David Greer; Nai Fang Chi; Janet Halliday; Kevin N Sheth
Journal:  Neurocrit Care       Date:  2015-10       Impact factor: 3.210

8.  Cohort-Based Identification of Predictors of Symptomatic Intracerebral Hemorrhage After IV Thrombolysis.

Authors:  David Asuzu; Karin Nyström; Hardik Amin; Joseph Schindler; Charles Wira; David Greer; Nai Fang Chi; Janet Halliday; Kevin N Sheth
Journal:  Neurocrit Care       Date:  2015-12       Impact factor: 3.210

9.  Defining clinically relevant cerebral hemorrhage after thrombolytic therapy for stroke: analysis of the National Institute of Neurological Disorders and Stroke tissue-type plasminogen activator trials.

Authors:  Neal M Rao; Steven R Levine; Jeffrey A Gornbein; Jeffrey L Saver
Journal:  Stroke       Date:  2014-08-05       Impact factor: 7.914

10.  Comparison of 8 scores for predicting symptomatic intracerebral hemorrhage after IV thrombolysis.

Authors:  David Asuzu; Karin Nystrom; Hardik Amin; Joseph Schindler; Charles Wira; David Greer; Nai Fang Chi; Janet Halliday; Kevin N Sheth
Journal:  Neurocrit Care       Date:  2015-04       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.